Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Drugs in R&D
|
September 30, 2015
Stability of Crushed Tedizolid Phosphate Tablets for Nasogastric Tube Administration
Gerard Kennedy, Jim Osborn, Shawn Flanagan, et al.
Clinical Pharmacology in Drug Development
|
December 4, 2019
Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects
Shawn Flanagan, Daniel B Goodman, Alena Jandourek, et al.
Pharmacotherapy
|
July 4, 2014
Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid
Shawn Flanagan, Edward Fang, Kelly A Muñoz, et al.
Journal of Athletic Training
|
November 5, 2020
Network Analysis of Sport-related Concussion Research During the Past Decade (2010-2019)
Shawn R Eagle, Anthony P Kontos, Michael W Collins, et al.
Pharmacotherapy
|
June 6, 2024
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects
Shawn Flanagan, Voon Ong, Thomas Marbury, et al.
Clinical and Translational Science
|
April 19, 2022
A phase I randomized, double-blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects
Kenan Gu, Dennis Ruff, Cassandra Key, et al.
Expert Opinion on Drug Safety
|
March 13, 2018
Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infections
Cathy Hardalo, Thomas P Lodise, Monique Bidell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 20, 2025
Absorption, distribution, metabolism, and excretion of an antiviral drug-Fc conjugate CD388 following subcutaneous administration of <sup>14</sup>C-CD388 in the rat
Aline Laenen, Shawn Flanagan, Grayson Hough, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 31, 2014
Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate
Voon Ong, Shawn Flanagan, Edward Fang, et al.
Antimicrobial Agents and Chemotherapy
|
October 31, 2018
Use of Translational Pharmacokinetic/Pharmacodynamic Infection Models To Understand the Impact of Neutropenia on the Efficacy of Tedizolid Phosphate
Jianying Xiao, Charles Gill, Lianzhu Liang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Drugs in R&D
|
September 30, 2015
Stability of Crushed Tedizolid Phosphate Tablets for Nasogastric Tube Administration
Gerard Kennedy, Jim Osborn, Shawn Flanagan, et al.
Clinical Pharmacology in Drug Development
|
December 4, 2019
Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects
Shawn Flanagan, Daniel B Goodman, Alena Jandourek, et al.
Pharmacotherapy
|
July 4, 2014
Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid
Shawn Flanagan, Edward Fang, Kelly A Muñoz, et al.
Journal of Athletic Training
|
November 5, 2020
Network Analysis of Sport-related Concussion Research During the Past Decade (2010-2019)
Shawn R Eagle, Anthony P Kontos, Michael W Collins, et al.
Pharmacotherapy
|
June 6, 2024
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects
Shawn Flanagan, Voon Ong, Thomas Marbury, et al.
Clinical and Translational Science
|
April 19, 2022
A phase I randomized, double-blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects
Kenan Gu, Dennis Ruff, Cassandra Key, et al.
Expert Opinion on Drug Safety
|
March 13, 2018
Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infections
Cathy Hardalo, Thomas P Lodise, Monique Bidell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 20, 2025
Absorption, distribution, metabolism, and excretion of an antiviral drug-Fc conjugate CD388 following subcutaneous administration of <sup>14</sup>C-CD388 in the rat
Aline Laenen, Shawn Flanagan, Grayson Hough, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 31, 2014
Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate
Voon Ong, Shawn Flanagan, Edward Fang, et al.
Antimicrobial Agents and Chemotherapy
|
October 31, 2018
Use of Translational Pharmacokinetic/Pharmacodynamic Infection Models To Understand the Impact of Neutropenia on the Efficacy of Tedizolid Phosphate
Jianying Xiao, Charles Gill, Lianzhu Liang, et al.
Page
of 3